BridgeMD
New treatment option for Bloodstream Infection
Official title The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
ClinicalTrials.gov ID: NCT06576258
What this study is testing
- What it's testing
- A quality improvement study on the diagnostics and clinical management of bloodstream infection episodes. Patients of all ages and genders with positive blood cultures collected for standard patient care are included in the study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with onset of BSI at the emergency department or general wards
- Patients hospitalized from blood draw (at least 24h)
- For pediatric patient only BSI episodes caused by gram-negative organisms
You likely can't join if
- Patients deceased at the time of the positive blood culture
- Patients in comfort care or with an estimated survival before sepsis of less than one month
- Patients with positive blood culture bottles within the past 14 days
- Patients for which the blood bottles are highly suspected of contaminants (bacterial species belonging to potential skin commensals or known...
The study team makes the final eligibility decision.
Where it's taking place
- Edegem, Antwerp, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edegem, Antwerp, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.